InveniAI and Kyowa Kirin Enter AI-Powered Novel Target Discovery Collaboration

InveniAI and Kyowa Kirin have been collaborating since 2018, to maximize Kyowa Kirins portfolio value through the re-innovation of an existing therapeutic pipeline into new disease indications utilizing AlphaMeld.